Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Lincoln Pharmaceuticals Ltd

LINCOLN.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$6.43

▼ -0.98%

Market Cap $128.73M · Vol 134.77K

Key Metrics

P/E Ratio

12.74

FWD: N/A

Market Cap

$128.73M

Micro Cap

Div Yield

0.29%

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

64.61

Momentum

Beta

0.90

vs Market

52W High

$8.07

20.13% below

52W Low

$4.61

34.42% above

Volume

134.77K

Avg 63.41K

P/B

1.49

Price-to-book

ROE

N/A

Return on equity

Free Float

43.88%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Lincoln Pharmaceuticals Ltd (LINCOLN.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does LINCOLN.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+2.21%

+1.06%

-7.90%

-6.25%

YTD

+26.75%

+13.04%

+15.26%

+86.76%

Financials & Valuation

TTM · Annual

Total Revenue	$71.80M
Net Income	$9.40M
Revenue Growth (YoY)	+15.07%
Gross Margin	51.47%
Operating Margin	12.40%
Net Profit Margin	13.10%
ROE	N/A
ROA · ROIC	13.70% · 12.37%

P/E Ratio	12.74
Forward P/E (FY1)	N/A
PEG Ratio	1.91
P/S	1.69
P/B	1.49
P/FCF	14.29
EPS Growth	N/A
Outstanding Shares	20.03M

Technical Indicators

50-Day SMA	$6.38
200-Day SMA	$6.00
RSI (14)	64.61
Beta	0.90
52-Week High	$8.07
52-Week Low	$4.61

Volume Today	134.77K
Avg Daily Volume (30D)	63.41K
Relative Volume	2.13x
Volatility (10D)	28.72
Volatility (30D)	25.05
Free Float	43.88%

Analyst Consensus

N/A

Current Price $6.43

Mean Target N/A

52W Low$4.61 52W High$8.07

Current

Target

$4.61 $8.07

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG001S8X912

ISININE405C01035

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Lincoln Pharmaceuticals Limited is engaged in the business of manufacturing and trading pharmaceutical products, as well as undertaking contract manufacturing from pharmaceuticals companies across India and the globe. The Company’s product categories include tablets, capsules, liquid injection, cream in tubes, eye/ear drops, dry power injection, SVP injectables, dry-powder suspensions, liquid injection, and pharma products. It offers products for anti-infective, respiratory system, gynecology, cardio and CNS (central nervous system), antibacterial, dermatological infection, anti-diabetic, and anti-malaria. The Company is also engaged in building a portfolio of lifestyle and chronic segments, primarily in women’s healthcare and dermatology. The Company caters to approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia, and 26 states across India. The Company has two manufacturing facilities located in Mehsana and Khatraj, Gujarat.